PHARMACOLOGIC APPROACH TO THE TREATMENT OF SHOCK.
D002395:Catecholamines; D004358:Drug Therapy; D004983:Ethanolamines; D006321:Heart; D006801:Humans; D008616:Mephentermine; D008680:Metaraminol; D008694:Methamphetamine; D009638:Norepinephrine; D010600:Pharmacology; D012769:Shock; D013565:Sympatholytics; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
D002395:Catecholamines; D004983:Ethanolamines; D013565:Sympatholytics; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D008694:Methamphetamine; D008680:Metaraminol; D008616:Mephentermine; D009638:Norepinephrine; C084832:pronethalol
CATECHOLAMINES; DRUG THERAPY; HEART; MEPHENTERMINE; METARAMINOL; METHAMPHETAMINE; NOREPINEPHRINE; PHARMACOLOGY; PRONETHALOL; REVIEW; SHOCK; SYMPATHOLYTICS; SYMPATHOMIMETICS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS